dehydrogenas
ratelimit
enzym
pentos
phosphat
pathway
modul
cellular
redox
homeostasi
via
regener
nadph
cell
reduc
abil
induc
innat
immun
respons
thu
increas
host
suscept
pathogen
infect
import
part
immun
respons
activ
inflammasom
peripher
blood
mononuclear
cell
pbmc
patient
human
monocyt
cell
use
model
investig
whether
modul
inflammasom
activ
decreas
express
observ
pbmc
pmaprim
cell
upon
lipopolysaccharid
lp
adenosin
triphosph
atp
lpsnigericin
stimul
express
cell
decreas
knockdown
transcript
translat
level
investig
express
inflammasom
subunit
phosphoryl
mapk
downstream
cfo
express
decreas
upon
knockdown
accompani
decreas
transloc
nucleu
impair
inflammasom
activ
cell
mediat
decreas
product
reactiv
oxygen
speci
ro
nox
signal
treatment
hydrogen
peroxid
h
enhanc
inflammasom
activ
cell
knockdown
decreas
staphylococcu
aureu
escherichia
coli
clearanc
cell
pbmc
follow
inflammasom
activ
find
support
notion
enhanc
pathogen
suscept
defici
part
due
alter
redox
signal
advers
affect
inflammasom
activ
bactericid
respons
abbrevi
dehydrogenas
nadph
reduc
form
nicotinamid
adenin
dinucleotid
phosphat
nox
nadph
oxidas
nitric
oxid
no
nitric
oxid
synthas
uplp
ultrapur
lipopolysaccharid
pma
phorbol
atp
adenosin
triphosph
mapk
mitogenactiv
protein
kinas
activ
protein
ro
reactiv
oxygen
speci
pbmc
peripher
blood
mononuclear
cell
h
hydrogen
peroxid
human
monocyt
cell
knockdown
although
dehydrogenas
defici
perhap
common
sexlink
enzymopathi
earth
biochem
physiolog
role
housekeep
enzym
fulli
explor
biochem
well
known
ratelimit
enzym
pentos
phosphat
pathway
regener
nicotinamid
adenin
dinucleotid
phosphat
nadph
nadph
essenti
cofactor
redox
system
maintain
proper
level
reduc
equival
reduc
glutathion
gsh
act
substrat
nadph
oxidas
nox
nitric
oxid
synthas
no
gener
reactiv
oxygen
speci
ro
nitric
oxid
respect
subsequ
role
signal
transduct
physiolog
evid
emerg
indic
defici
affect
glucos
metabol
cell
growth
embryon
develop
lethal
suscept
infect
modul
redox
homeostasi
defici
disrupt
immun
respons
clearli
delin
sinc
play
vital
role
cellular
redox
homeostasi
enzym
influenc
redox
microenviron
cell
lead
modul
physiolog
function
nox
major
sourc
ro
involv
initi
cell
signal
modul
inflammatori
respons
antimicrobi
defens
phagocyt
transcript
factor
certain
signal
transduct
pathway
protein
mapk
activ
intracellular
ro
induc
inflammatori
signal
patient
defici
knockdown
cell
suscept
pathogen
infect
indic
immun
respons
affect
statu
key
physiolog
function
innat
immun
respons
activ
inflammasom
mainli
lead
product
proinflammatori
cytokin
especi
respons
invad
pathogen
common
inflammasom
includ
classifi
oligom
composit
differ
stimuli
among
inflammasom
stimul
environmentaland
pathogenhostderiv
factor
process
mediat
inflammasom
critic
microbi
infect
includ
regul
metabol
process
mucos
immun
respons
activ
inflammasom
requir
strict
regul
otherwis
lead
mani
diseas
involv
activ
inflammasom
clearli
defin
activ
inflammasom
ro
depend
mediat
nox
pathway
decreas
ro
product
observ
granulocyt
upon
lipopolysaccharid
lp
phorbol
pma
stimul
abnorm
attribut
impair
nox
signal
increas
suscept
pathogen
infect
cell
due
insuffici
rostrigg
inflammatori
respons
find
provid
support
notion
defici
impair
ro
product
via
nox
signal
pathway
effect
inflammasom
activ
deserv
attent
current
studi
decreas
observ
pbmc
patient
defici
cell
led
investig
role
inflammasom
activ
associ
bactericid
effect
phagocyt
mechanist
defici
provid
less
nadph
substrat
nox
caus
less
ro
gener
activ
inflammasom
ficollpaqu
purchas
ge
healthcar
littl
halfont
buckinghamshir
uk
ultrapur
lp
purchas
invivogen
california
usa
antierk
antiphosphoerk
antijnk
antiphosphojnk
anticjun
antiphosphocjun
antiphosphocfo
anticfo
purchas
cell
signal
technolog
beverli
usa
purchas
genesi
biotech
taiwan
atp
nigericin
pma
hydrogen
peroxid
dpi
nadph
purchas
sigmaaldrich
st
loui
mo
usa
purchas
adipogen
life
scienc
san
diego
ca
usa
antiasc
purchas
medic
biolog
laboratori
japan
antimous
antirabbit
antibodi
purchas
santa
cruz
biotechnolog
dalla
tx
usa
purchas
merck
millipor
burlington
usa
antilamin
purchas
proteintech
illinoi
usa
polyvinyliden
difluorid
pvdf
membran
immobilon
western
chemiluminesc
hrp
substrat
ecl
purchas
millipor
corpor
billerica
usa
studi
approv
institut
review
board
chang
gung
memori
hospit
written
inform
consent
acquir
everi
volunt
human
whole
blood
taken
healthi
volunt
patient
nonsmok
medic
background
pbmc
isol
whole
blood
use
ficollpaqu
densiti
gradient
centrifug
kind
gift
dr
hsingi
huang
chang
gung
univers
cultur
rpmi
gibco
usa
supplement
fb
biolog
industri
usa
unitsml
penicillin
streptomycin
gibco
usa
humidifi
atmospher
co
human
embryon
kidney
cell
line
purchas
american
type
cultur
collect
rockvil
md
usa
cultur
dulbecco
modifi
eagl
medium
gibco
usa
supplement
fb
unitsml
penicillin
streptomycin
humidifi
atmospher
co
specif
set
human
sirna
univers
neg
control
obtain
dharmacon
rna
technolog
lafayett
co
usa
transfect
target
sirna
nm
per
cell
perform
use
lipofectamin
reagent
invitrogen
ca
usa
base
manufactur
instruct
next
day
cell
treat
stimuli
describ
pbmc
isol
whole
blood
incub
lp
ml
h
atp
mm
anoth
h
supernat
collect
determin
elisa
kit
cell
cultur
presenc
ngml
pma
allow
differenti
macrophagelik
cell
incub
h
cell
incub
fresh
rpmi
anoth
h
follow
lp
treatment
nigericin
treatment
cell
lysat
supernat
collect
indic
experi
cell
supernat
harvest
human
quantif
use
elisa
kit
r
system
minneapoli
mn
accord
manufactur
instruct
activ
whole
blood
measur
use
quantit
kit
triniti
biotech
accord
manufactur
instruct
brief
assay
reagent
whole
blood
ad
cuvett
incub
min
room
temperatur
ml
substrat
solut
ad
cuvett
incub
min
reduct
nadp
measur
spectrophotometr
nm
activ
express
erythrocyt
rbc
activ
measur
spectrophotometr
nm
reduct
nadp
presenc
previous
describ
brief
cell
lyse
lysi
buffer
mm
trishcl
mm
nacl
mm
edta
sd
mm
naf
tritonx
ph
centrifug
cell
lysat
react
assay
buffer
mm
trishcl
ph
mm
mgcl
mm
nadp
mm
glucos
activ
analyz
nm
spectrophotometri
beckman
coulter
usa
total
protein
lysat
supernat
analyz
western
blot
cell
collect
use
lysi
buffer
mm
trishcl
mm
nacl
mm
edta
sd
mm
naf
tritonx
ph
protein
concentr
determin
bradford
assay
protein
supernat
concentr
trichloroacet
acid
tca
precipit
sampl
denatur
electrophores
sdspolyacrylamid
gel
transfer
onto
pvdf
membran
membran
incub
overnight
appropri
dilut
primari
antibodi
membran
incub
appropri
dilut
hrpconjug
secondari
antibodi
h
immunoreact
band
visual
ecl
reagent
imagej
softwar
use
analyz
intens
use
load
control
total
rna
extract
use
trizol
reagent
life
technolog
ca
usa
rna
revers
transcrib
cdna
oligodt
bioman
scientif
taipei
taiwan
primer
presenc
revers
transcriptas
superscript
iii
invitrogen
qrtpcr
conduct
use
supermix
reagent
biorad
ca
usa
realtim
thermal
cycler
biorad
ca
usa
express
level
normal
endogen
actb
data
analyz
use
method
sequenc
primer
use
qrtpcr
follow
actb
human
promot
plasmid
kind
gift
dr
benkuen
chen
nation
cheng
kung
univers
delet
sequenc
bind
site
bear
luciferas
plasmid
construct
use
sitedirect
mutagenesi
cell
cultur
plate
transfect
ng
plkoscrambl
togeth
ng
promot
plasmid
wildtyp
delet
ng
prltk
vector
thermo
fisher
scientif
usa
fortyeight
hour
transfect
luciferas
activ
measur
use
dualluciferas
assay
promega
usa
glomax
luminomet
promega
usa
cellular
extract
assay
luciferas
activ
normal
renilla
luciferas
level
data
present
rel
plkoscrambl
level
rel
light
unit
rlu
cell
incub
min
cmh
dcfda
thermo
fisher
scientif
usa
cell
detach
well
min
incub
pb
contain
mm
edta
min
incub
trypsinedta
cell
wash
twice
resuspend
pb
contain
fb
flow
cytometri
fcm
analysi
fcm
data
present
mean
fluoresc
intens
mfi
cell
superoxid
product
measur
use
cytochrom
c
reduct
accord
previou
studi
sinc
cytochrom
c
enter
cell
assay
exclus
determin
superoxid
produc
nox
extracellular
medium
brief
pmatreat
cell
ml
seed
well
plate
allow
differenti
macrophagelik
cell
incub
h
cell
incub
fresh
rpmi
anoth
h
cell
incub
prewarm
hbss
contain
cytochrom
c
stimul
lp
absorb
nm
record
min
measur
per
min
gentl
shake
product
superoxid
calcul
use
absorpt
coeffici
mm
cm
cytochrom
c
staphylococcu
aureu
escherichia
coli
incub
luriabertani
lb
media
shake
one
day
experi
densiti
bacteria
measur
nm
du
spectrophotomet
wash
three
time
pb
lpsprime
cell
pbmc
subject
infect
bacteria
moi
multipl
infect
incub
h
humidifi
atmospher
co
infect
cell
wash
three
time
hbss
incub
gentamicin
contain
rpmi
min
kill
extracellular
bacteria
replac
medium
fresh
medium
cell
incub
nigericin
min
induc
inflammasom
activ
cell
wash
hbss
follow
lysi
triton
cell
lysat
serial
dilut
spread
onto
correl
activ
secret
cell
transfect
sirna
nm
pmadifferenti
treat
lp
nigericin
cell
lysat
supernat
collect
activ
analysi
data
repres
three
independ
experi
n
p
agar
plate
next
day
effici
bacteri
clearanc
determin
count
coloni
form
unit
cfu
agar
plate
signific
activ
concentr
activ
intracellular
bacteri
clearanc
normal
patient
evalu
mannwhitney
test
data
express
mean
sem
replic
determin
signific
correl
activ
assess
pearson
correl
student
ttest
use
compar
mean
valu
control
cell
compar
superoxid
product
express
mean
sem
replic
determin
data
express
mean
standard
deviat
least
three
separ
experi
differ
regard
signific
p
valu
ten
patient
defici
healthi
control
recruit
studi
tabl
patient
defici
normal
control
subject
within
age
rang
point
mutat
site
gene
patient
defici
tabl
activ
whole
blood
patient
defici
much
lower
normal
control
fig
secret
significantli
decreas
human
pbmc
fig
compar
normal
control
pbmc
indic
defici
associ
lower
product
activ
posit
correl
secret
fig
cell
express
approxim
level
control
cell
fig
accord
result
mtt
assay
cell
count
cell
viabil
similar
control
cell
fig
similar
observ
pbmc
patient
fig
cell
decreas
secret
upon
inflammasom
activ
fig
pattern
protein
express
cell
lysat
supernat
found
elisa
fig
quantit
intens
cell
lysat
supernat
shown
fig
e
respect
activ
posit
correl
secret
fig
knockdown
reduc
express
matur
express
compon
inflammasom
asc
fig
decreas
translat
level
upon
inflammasom
activ
detect
western
blot
fig
cell
compar
level
control
quantit
intens
shown
fig
mrna
level
also
decreas
cell
fig
phosphoryl
differ
time
point
upon
inflammasom
activ
decreas
cell
compar
control
cell
without
chang
phosphoryl
level
erk
jnk
fig
quantit
intens
shown
fig
control
cell
treat
inhibitor
mapk
result
inhibit
fig
cell
react
lp
result
impair
pro
express
fig
quantit
intens
shown
fig
f
respect
total
phosphoryl
form
cfo
cjun
decreas
without
lp
treatment
cell
fig
quantit
intens
pcfo
cfo
shown
fig
c
respect
signal
heterodim
cfo
cjun
downstream
decreas
treatment
control
cell
fig
quantit
intens
cfo
shown
fig
lp
treatment
promot
transloc
cjun
cfo
cytoplasm
nucleu
control
cell
fig
transloc
cfo
reduc
cell
although
cjun
transloc
increas
upon
knockdown
compar
scrambl
control
cell
signific
differ
observ
transloc
quantif
nuclear
cfo
shown
fig
report
plasmid
construct
shown
fig
upper
panel
cell
chosen
measur
bind
activ
eas
transfect
cell
compar
cell
bind
activ
lower
cell
compar
bind
activ
plkoscrambl
cell
fig
impair
signal
knockdown
presenc
decreas
ro
product
cell
treatment
differenti
control
cell
lp
nigericin
increas
ro
product
less
cell
fig
product
superoxid
lower
cell
control
cell
upon
lp
incub
min
fig
pretreat
control
cell
dpi
inhibitor
nadph
oxidas
decreas
express
cell
fig
e
quantit
intens
shown
fig
f
respect
cell
treat
h
nadph
increas
express
fig
quantit
intens
shown
fig
j
respect
express
improv
overexpress
cell
fig
variabl
ro
level
differ
effect
cellular
physiolog
fig
express
induc
high
concentr
h
treat
cell
suggest
defici
decreas
ro
level
affect
inflammasom
signal
pathway
signal
pmadifferenti
control
cell
treat
min
prior
lp
treatment
min
detect
min
detect
e
f
quantit
level
c
use
normal
load
control
result
repres
three
independ
experi
n
p
gramposit
aureu
fig
b
gramneg
e
coli
fig
analyz
bacteri
clearanc
activ
pbmc
patient
defici
cfu
number
higher
cell
pbmc
patient
defici
compar
cfu
number
scrambl
control
cell
pbmc
normal
control
pathogen
impair
bactericid
effect
due
defici
could
improv
ad
certain
chronic
infecti
diseas
associ
defici
impact
statu
innat
immun
especi
upon
inflammasom
activ
unknown
present
studi
first
show
cell
pbmc
patient
defici
differ
mutat
enzym
decreas
express
inflammasom
e
cfo
quantit
level
use
normal
load
control
result
repres
three
independ
experi
n
p
f
western
blot
cytoplasm
nuclear
protein
cell
treat
lp
min
lamin
use
cytoplasm
nuclear
load
control
g
cfo
quantit
level
f
result
repres
three
independ
experi
n
p
h
luciferas
activ
assay
cell
transfect
firefli
luciferas
report
plasmid
contain
partial
sequenc
put
bind
site
wt
delet
mutat
assay
standard
renilla
activ
transfect
h
p
compar
basal
condit
activ
defect
inflammasom
activ
could
attribut
inhibit
signal
upon
lp
stimul
underli
mechan
due
decreas
superoxid
product
nox
found
cell
togeth
result
indic
defici
impair
cellular
innat
immun
respons
disturb
redox
homeostasi
clinic
implic
individu
infecti
diseas
import
maintain
cellular
redox
homeostasi
regener
nadph
substrat
nox
no
format
superoxid
nox
depend
electron
transfer
cytoplasm
nadph
extracellular
oxygen
superoxid
reduc
extracellular
superoxid
dismutas
produc
h
transfer
cell
aquaporin
channel
influx
cytoplasm
chlorid
initi
intracellular
signal
sinc
activ
nox
modul
statu
pathwaymedi
inflammatori
respons
impair
defici
defici
increas
cellular
suscept
varieti
pathogeninduc
viral
bacteri
infect
compar
level
normal
phagocyt
phagocyt
lower
level
superoxid
ro
need
effect
microbi
kill
suscept
microbi
infect
patient
defici
may
due
impair
respons
absenc
netosi
still
unknown
defens
mechan
present
studi
show
inflammasom
respons
modul
statu
provid
addit
mechan
defici
increas
suscept
infect
propos
fig
level
ro
signific
consequ
variou
cellular
function
cytotox
level
ro
oxid
burst
phagocyt
cell
particip
host
defens
direct
kill
foreign
pathogen
hand
cytoregulatori
level
ro
mediat
intracellular
signal
maintain
proper
redox
environ
regul
mani
cellular
signal
pathway
present
studi
provid
evid
support
notion
cytoregulatori
level
ro
influenc
pathway
bactericid
effect
defici
cell
pathway
inflammasom
activ
involv
two
signal
includ
prime
signal
activ
signal
result
indic
defici
influenc
pathway
signal
express
inflammasom
subunit
influenc
signal
suggest
low
concentr
ro
defici
affect
signal
signal
furthermor
express
found
improv
lowdos
mm
h
treat
cell
fig
contrast
secret
detect
high
level
h
stimul
fig
high
concentr
ro
lead
cell
undergo
apoptosi
pyroptosi
common
program
cell
death
upon
inflammasom
activ
contrast
cytoregulatori
level
ro
import
cell
regul
cellular
signal
transduct
ro
affect
inflammasom
activ
via
signal
high
concentr
cytotox
level
wherea
low
concentr
ro
involv
regul
signal
inflammasom
activ
cell
need
maintain
redox
homeostasi
regul
proper
function
redox
pathway
identifi
cell
broad
function
relay
gener
cellular
signal
sinc
play
role
product
nadph
substrat
nox
anticip
may
involv
modul
redoxsensit
signal
nadph
decreas
superoxid
product
reduc
nox
may
caus
impair
antioxid
respons
decreas
signal
signal
part
redox
pathway
therebi
contribut
activ
redox
network
transcript
factor
heterodim
compos
protein
cfo
cjun
atf
famili
stabil
junfo
heterodim
allow
higher
dnabind
activ
knockdown
decreas
phosphoryl
cfo
express
reduc
express
termin
differenti
cell
associ
induct
cfo
impli
could
growth
arrest
signal
differenti
monocyt
number
redoxrel
transcript
factor
modul
statu
indic
import
cellular
redox
homeostasi
hemolyt
crisi
diabet
hypertens
infecti
diseas
protect
malaria
associ
defici
patient
defici
suscept
infect
may
involv
novel
mechan
includ
impair
inflammasom
activ
moreov
nadph
also
substrat
mani
protect
enzym
antioxid
defenc
may
play
role
iflammasom
activ
nad
p
h
quinon
major
quinon
reductas
requir
nadph
electron
donor
catalyz
quinon
hydroquinon
enzym
also
play
antioxid
enzym
cellular
redox
homeostasi
induct
mediat
mechan
varieti
stress
respons
presum
cellular
protect
system
term
inflammatori
respons
inhibitor
immun
respons
promot
degrad
lead
impair
tlrmediat
product
cytokin
glutathion
also
antioxid
play
critic
role
mani
metabol
process
previou
metabolom
studi
shown
alter
statu
affect
cellular
metabol
pathway
abnorm
glycerophospholipid
metabol
defici
embryo
lead
defect
embryon
develop
defici
cell
unabl
regener
enough
nadph
stress
situat
rapid
switch
gsh
biosynthet
suppli
caus
energi
crisi
ineffect
ampk
activ
howev
whether
defici
affect
inflammasom
activ
via
chang
antioxid
metabolit
need
investig
sinc
infecti
metabol
diseas
patient
defici
may
sever
patient
normal
level
concur
notion
escal
diagnost
algorithm
includ
determin
activ
patient
although
induct
inflammasom
contribut
host
defens
infect
dysregul
inflammasom
associ
mani
human
diseas
cancer
autoimmun
diseas
inflammatori
disord
find
inhibit
attenu
inflammasom
activ
suggest
new
approach
therapeut
intervent
inflammasomeassoci
diseas
inflammasom
target
henc
inhibitor
polydatin
might
consid
therapeut
agent
attenu
inflammasomeassoci
diseas
conclus
impair
inflammasom
activ
defici
present
phenomenon
increas
suscept
bacteri
infect
mechanist
defect
bacteri
clearanc
found
cell
due
impair
signal
may
appear
patient
defici
chang
statu
contribut
imbal
cellular
redox
homeostasi
affect
inflammatoryassoci
signal
transduct
influenc
cellular
infect
care
patient
defici
prevent
infect
might
includ
appropri
antibiot
prophylaxi
modul
inflammasom
activ
knockdown
result
reduc
gener
impair
lpsinduc
pathway
secret
also
reduc
cell
author
codesign
experi
experi
perform
weichen
yen
yihsuan
wu
hsinru
lin
author
analyz
result
wrote
manuscript
contribut
substanti
present
work
read
approv
final
manuscript
author
declar
conflict
interest
